About this Journal Submit a Manuscript Table of Contents
Advances in Hematology
Volume 2012 (2012), Article ID 727683, 12 pages
http://dx.doi.org/10.1155/2012/727683
Research Article

Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine

1Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, 1725 West Harrison Street, Chicago, IL 60612, USA
2Rush University Cancer Center, 1725 West Harrison Street, Chicago, IL 60612, USA
3Section of Hematology, Rush University Medical Center, 1725 West Harrison Street, Chicago, IL 60612, USA
4Department of Anatomy and Cell Biology, Rush University Medical Center, 1725 West Harrison Street, Chicago, IL 60612, USA

Received 18 June 2012; Accepted 4 August 2012

Academic Editor: Seiji Fukuda

Copyright © 2012 Sucheta Jagan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sucheta Jagan, Laura A. Paganessi, Robin R. Frank, Parameswaran Venugopal, Melissa Larson, and Kent W. Christopherson, II, “Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine,” Advances in Hematology, vol. 2012, Article ID 727683, 12 pages, 2012. doi:10.1155/2012/727683